US FDA De Novo submission is a regulatory route for low to moderate-risk medical devices that lack a predicate device. It enables manufacturers to classify novel devices into Class I or Class II. This allows the device to be marketed in the US. Additionally, it can...
You cannot copy content of this page
Contact Us!
Chat with Us on WhatsApp! We reply within 5 minutes!
